<?xml version="1.0" encoding="UTF-8"?>
<p id="par0020">Immunosuppressive drugs and disease modifying antirheumatic medicines are widely used in the treatment of connective tissue disease. However, usage of immunosuppressive medications is associated with increased risk of severe infection [
 <xref rid="bib0005" ref-type="bibr">1</xref>]. Varicella zoster infection can be caused by primary infection or reactivation. Risk of reactivation is related to age-related immune senescence or immunocompromised status. Complications include cutaneous dissemination and serious visceral organ involvement such as severe pneumonia, hepatitis and meningo-encephalitis. Post exposure varicella immune globulin and prompt antiviral therapy may contribute to decrease disease progression in immunocompromised patients [
 <xref rid="bib0010" ref-type="bibr">2</xref>,
 <xref rid="bib0015" ref-type="bibr">3</xref>]. In this case report, we described a fulminant clinical course of varicella zoster infection in a immunosuppressed host after contact with varicella zoster patients.
</p>
